scPharmaceuticals Inc (SCPH)
US Market

scPharmaceuticals (SCPH) Stock Price & Analysis


SCPH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.68 - $10.38
Previous Close$6.85
Average Volume (3M)509.54K
Market Cap
Enterprise Value$198.67M
Total Cash (Recent Filing)$45.19M
Total Debt (Recent Filing)$10.59M
Price to Earnings (P/E)-5.4
Mar 22, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.27
Shares Outstanding34,054,083
10 Day Avg. Volume1,150,128
30 Day Avg. Volume509,540
Standard Deviation0.21
Financial Highlights & Ratios
Price to Book (P/B)10.37
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-14.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.12
Price Target Upside94.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was scPharmaceuticals Inc’s price range in the past 12 months?
scPharmaceuticals Inc lowest stock price was $3.68 and its highest was $10.38 in the past 12 months.
    What is scPharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is scPharmaceuticals Inc’s upcoming earnings report date?
    scPharmaceuticals Inc’s upcoming earnings report date is Mar 22, 2023 which is tomorrow.
      How were scPharmaceuticals Inc’s earnings last quarter?
      scPharmaceuticals Inc released its earnings results on Nov 09, 2022. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.382 by $0.012.
        Is scPharmaceuticals Inc overvalued?
        According to Wall Street analysts scPharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does scPharmaceuticals Inc pay dividends?
          scPharmaceuticals Inc does not currently pay dividends.
          What is scPharmaceuticals Inc’s EPS estimate?
          scPharmaceuticals Inc’s EPS estimate is -$0.39.
            How many shares outstanding does scPharmaceuticals Inc have?
            scPharmaceuticals Inc has 34,054,085 shares outstanding.
              What happened to scPharmaceuticals Inc’s price movement after its last earnings report?
              scPharmaceuticals Inc reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.382. Following the earnings report the stock price went up 12.268%.
                Which hedge fund is a major shareholder of scPharmaceuticals Inc?
                Among the largest hedge funds holding scPharmaceuticals Inc’s share is RA Capital Management. It holds scPharmaceuticals Inc’s shares valued at 13M.


                  scPharmaceuticals Stock Smart Score

                  The scPharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  scPharmaceuticals Inc

                  scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Harrow Health
                  CymaBay Therapeutics
                  Rain Therapeutics
                  Theseus Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis